INS and pregnancy disorder: The metformin group had lower risks of primary cesarean section (aOR, 0.50; 95% CI, 0.30–0.83; p = 0.008) and congenital malformations (aOR, 0.40; 95% CI, 0.17–0.93; p = 0.033) than did the insulin group.